Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 3
2004 9
2005 7
2006 12
2007 7
2008 7
2009 3
2010 3
2011 3
2012 6
2013 4
2014 5
2015 1
2017 3
2018 4
2019 3
2021 2
2022 7
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

88 results

Results by year

Filters applied: . Clear all
Page 1
Feasibility of Coacervate-Like Nanostructure for Instant Drug Nanoformulation.
Zhu GH, Azharuddin M, Pramanik B, Roberg K, Biswas SK, D'arcy P, Lu M, Kaur A, Chen A, Dhara AK, Chivu A, Zhuang Y, Baker A, Liu X, Fairen-Jimenez D, Mazumder B, Chen R, Kaminski CF, Kaminski Schierle GS, Hinkula J, Slater NKH, Patra HK. Zhu GH, et al. Among authors: hinkula j. ACS Appl Mater Interfaces. 2023 Apr 12;15(14):17485-17494. doi: 10.1021/acsami.2c21586. Epub 2023 Mar 28. ACS Appl Mater Interfaces. 2023. PMID: 36976817 Free PMC article.
Effectiveness of the BNT162b2 mRNA Vaccine Compared with Hybrid Immunity in Populations Prioritized and Non-Prioritized for COVID-19 Vaccination in 2021-2022: A Naturalistic Case-Control Study in Sweden.
Spreco A, Dahlström Ö, Jöud A, Nordvall D, Fagerström C, Blomqvist E, Gustafsson F, Hinkula J, Schön T, Timpka T. Spreco A, et al. Among authors: hinkula j. Vaccines (Basel). 2022 Aug 7;10(8):1273. doi: 10.3390/vaccines10081273. Vaccines (Basel). 2022. PMID: 36016162 Free PMC article.
Intranasal Coronavirus SARS-CoV-2 Immunization with Lipid Adjuvants Provides Systemic and Mucosal Immune Response against SARS-CoV-2 S1 Spike and Nucleocapsid Protein.
Sengupta A, Azharuddin M, Cardona ME, Devito C, von Castelmur E, Wehlin A, Pietras Z, Sunnerhagen M, Selegård R, Aili D, Alamer A, Hinkula J, Al-Otaibi N. Sengupta A, et al. Among authors: hinkula j. Vaccines (Basel). 2022 Mar 24;10(4):504. doi: 10.3390/vaccines10040504. Vaccines (Basel). 2022. PMID: 35455253 Free PMC article.
88 results